Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Innovative radiotherapy offers a precision treatment alternative.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

The Boston-based startup Axonis Therapeutics has bagged $115 million in a Series A round to fuel its pipeline of treatments for pain, epilepsy and other conditions.

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations ...

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are the companies racing for approval of their own versions of these highly ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.